---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-000384"
form_type: "8-K"
ticker: "PHIO"
cik: "0001533040"
company_name: "Phio Pharmaceuticals Corp."
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T01:04:38.723442+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Phio prices $2.5M registered direct offering of 833,335 shares at $3.00/sh; concurrent private placement of warrants

## Summary
- Gross proceeds of $2.5M; net ~$2.2M after fees and expenses.
- Issued 833,335 common shares at $3.00/sh in registered direct offering.
- Concurrent private placement of short-term warrants for up to 1,666,670 shares at $3.00, exercisable for 24 months.
- Placement agent H.C. Wainwright receives 62,500 warrants at $3.75/sh plus cash fees.
- Proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001683168-25-000384
- form_type: 8-K
- ticker: PHIO
- cik: 0001533040
- company_name: Phio Pharmaceuticals Corp.
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533040/000168316825000384/0001683168-25-000384-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533040/000168316825000384/phio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-000384
- JSON: https://secwatch.observer/filing/0001683168-25-000384.json
- Plain text: https://secwatch.observer/filing/0001683168-25-000384.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.